Stem Cell Research 
in Diabetes

Research at the Medical University of South Carolina using mesenchymal stem cell infusion as an intervention for treating type 1 diabetes

77 -Study- (Solid)Created with Sketch.


Background on Type 1 Diabetes and Mesenchymal Stem Cells

Artboard 25

Clinical Trials

Current clinical trials


Contact researchers at MUSC

Research Background

Type 1 diabetes (T1D) is an autoimmune disease in which T cells attack and destroy insulin-secreting pancreatic β cells leading to insulin deficiency and hyperglycemia in patients. The standard treatment is life-long insulin therapy.  However, this therapy is not a cure and a safer and more effective therapy is needed.


Mesenchymal Stem Cells (MSCs) have emerged as a novel biopharmaceutical approach for many disorders. MSCs are a cellular product that can be derived from a patient's own body (autologous) or from a donor (allogeneic). Evidence from clinical trials suggests that MSC infusion suppresses autoimmune and inflammatory diseases, such as T1D. One clear message from these trials is that MSCs are effective at suppressing autoimmunity and appear generally safe.


For information please contact us 

(843) 792-2813

This website is created with Website Builder - Ucraft
i want a website like this
Ucraft is a free website builder that provides web designers, marketers and business owners with a set of web design tools to start their next awesome project in minutes. No coding or designer skills needed. Go to Ucraft